UCL Technology Fund-backed gene therapy developer MeiraGTx has gone public on Nasdaq after raising $75m in proceeds in its initial public offering.

Philippe Nérin will lead France’s tech transfer association Réseau Satt for one year from September 1.

Ascentage, based on research at University of Michigan, has increased its total funding to more than $240m after closing a $150m series C round.

MedWhat insists Stanford University failed to disclose a conflict of interest when it invested in rival virtual medical assistant developer Sensely.

University of New Mexico tempted all 11 new spinouts in 2017-18 to remain in the state, a marked improvement on the four companies that chose to remain during the previous year.

HealthCap has backed sickle cell disease therapy developer Modus Therapeutics, joining existing shareholders such as Karolinska Development.

Unnamed endowments have helped High Alpha launch its second enterprise software-focused fund and affiliated startup studio.

The Italian Space Agency has put its weight behind the $93m Astra Ventures that will invest in spinouts developing space technologies.

The personalised cancer therapy company has completed a $40m round that increased its funding to $76m altogether.